Singapore, Sept. 2 -- ChemPartner, a leading global Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), has announced its strategic expansion in the US with the upcoming opening of the ChemPartner Boston Centre of Excellence.

Located at 480 Arsenal Way in Watertown, MA, the new R&D site will commence operations on September 10, 2025, providing discovery and preclinical services to biopharma clients in North America and beyond.

ChemPartner's new US site, located in the heart of the Boston biotech corridor, is designed to strengthen collaboration with the region's innovative biotech and pharmaceutical community.

Offering biologics discovery, pharmacology, and DMPK services, the site suppor...